(Q43287633)

18 November 2017

title

Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis (English)

1 reference

18 November 2017

Miguel A Frias

1

1 reference

18 November 2017

Ursula Lang

series ordinal

2

1 reference

18 November 2017

Christine Gerber-Wicht

series ordinal

3

1 reference

18 November 2017

Richard W James

series ordinal

4

1 reference

18 November 2017

language of work or name

1 reference

1 January 2010

1 reference

18 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Cardiovascular Research

1 reference

18 November 2017

volume

85

1 reference

18 November 2017

issue

1

1 reference

18 November 2017

page(s)

118-126

1 reference

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Adriamycin-induced heart failure: mechanism and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

High-density lipoproteins and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Oxidative stress-elicited myocardial apoptosis during reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Role of the JAK-STAT pathway in myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Sphingosine 1-phosphate analogs as receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

The role of sphingosine-1-phosphate in smooth muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP289

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP289

1 reference

18 November 2017

1 reference